Prestige Wealth Management Group LLC Neurocrine Biosciences Inc Transaction History
Prestige Wealth Management Group LLC
- $460 Million
- Q3 2024
A detailed history of Prestige Wealth Management Group LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 25 shares of NBIX stock, worth $3,581. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25
Previous 23
8.7%
Holding current value
$3,581
Previous $3,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NBIX
# of Institutions
632Shares Held
93.9MCall Options Held
632KPut Options Held
621K-
Black Rock Inc. New York, NY14.2MShares$2.03 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$1.43 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.15MShares$738 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.57MShares$369 Million0.47% of portfolio
-
Bellevue Group Ag Kuesnacht, V81.86MShares$267 Million3.62% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.7B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...